0 NASDAQ Companies - December 10, 2018Achaogen Announces FDA Clearance and Launch of the Thermo Scientific QMS Plazomicin ImmunoassayThermo Fisher Scientific and Achaogen jointly develop new assay to enable Therapeutic Drug Management SOUTH SAN FRANCISCO, Calif., Dec. 10, […]Read More
0 TSX News - December 10, 2018TECSYS Receives a 2018 Supply & Demand Chain Executive Green Supply Chain AwardMONTREAL, Dec. 10, 2018 (GLOBE NEWSWIRE) — Supply & Demand Chain Executive, the executive’s user manual for successful supply and […]Read More
0 NYSE Companies - December 10, 2018VMware Receives Highest Product Scores in Two of Three Use Cases in Gartner’s Critical Capabilities for WAN Edge InfrastructureVMware is the highest ranked vendor for both Midsize Enterprise/Regional and Large Global WAN use cases PALO ALTO, Calif., Dec. […]Read More
0 NYSE Companies - December 10, 2018Pfenex Submits New Drug Application to U.S. FDA Seeking Approval of PF708 for the Treatment of OsteoporosisSubmitted as a 505(b)(2) NDA with an Expected Ten-Month Review SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) — Pfenex Inc. […]Read More
0 NYSE Companies - December 10, 2018Bonanza Creek Announces New $350 Million Borrowing BaseDENVER, Dec. 10, 2018 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (the “Company”) announced today that the Company […]Read More
0 NASDAQ Companies - December 10, 2018Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use DisorderCHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused […]Read More
0 NASDAQ Companies - December 10, 2018Catalyst Biosciences to Host a Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia ProgramsSOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused […]Read More
0 NASDAQ Companies - December 10, 2018Sci-Tech Discovery Center Announces Finisar as Presenting Sponsor of a Community Mobile Laser LabFinisar Mobile Laser Lab to Elevate STEM Programming for Middle and High School Students in Dallas/Fort Worth and Sherman FRISCO, […]Read More
0 NASDAQ Companies - December 10, 2018Genocea Appoints Girish Aakalu, Ph.D., Chief Business OfficerRole to focus on business development as Genocea expands its immunotherapy pipeline and explores additional applications of its ATLAS™ neoantigen […]Read More
0 NASDAQ Companies - December 10, 2018XpresSpa Announces First Franchise Partnership Agreement with Experienced Operator in the Health and Wellness IndustryWorld’s largest airport spa brand to open in a Texas based Airport during the First Quarter of 2019 NEW YORK, […]Read More